Pneumocystis jirovecii
pneumonia: a proposed novel model of corticosteroid benefit
Ther Adv Infect Dis
.
2021 Jul 20:8:20499361211032034.
doi: 10.1177/20499361211032034.
eCollection 2021 Jan-Dec.
Authors
Amal A Gharamti
1
,
William Mundo
2
,
Daniel B Chastain
3
,
Carlos Franco-Paredes
4
,
Andrés F Henao-Martínez
5
,
Leland Shapiro
4
Affiliations
1
Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
2
School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
3
Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA, USA.
4
Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, Aurora, CO, USA.
5
Department of Medicine, Division of Infectious Diseases, University of Colorado Denver, 12700 E. 19th Avenue, Mail Stop B168. Aurora, CO 80045, USA.
PMID:
34349985
PMCID:
PMC8295936
DOI:
10.1177/20499361211032034
No abstract available
Keywords:
AIDS; ARDS; HIV; Pneumocystis jirovecii; corticosteroids.